No Data
No Data
Express News | Inhibikase Therapeutics Announces Expansion Into Cardiopulmonary Disease
Express News | Inhibikase Therapeutics Inc: Will Submit Ind Application to FDA for Ikt-001Pro as Treatment for Pulmonary Arterial Hypertension Early in Q3
Express News | Inhibikase Therapeutics Inc: Scaling Process Development Efforts for Ikt-001Pro to Support Late-Stage Clinical Development & Nda Batch Requirements
Express News | Inhibikase Therapeutics Inc: Will Discontinue Development of Treatments for Progressive Multifocal Leukoencephalopathy
Express News | Inhibikase Therapeutics Announces Expansion to Its Therapeutic Pipeline and Updates Its Research and Development Programs
Inhibikase Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Inhibikase Therapeutics Is Maintained at Buy by HC Wainwright & Co.
No Data